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Abstract

EXAMINATION OF NAK-ASSOCIATED PROTEIN-1 (NAP1) HOMO AND HETEROINTERACTIONS IN THE INTERFERON PATHWAY
By R. Jason Call, M.S
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2011
Major Director: Dr. Jessica K. Bell, Ph.D.
Assistant Professor, Department of Biochemistry & Molecular Biology

Double stranded RNA (dsRNA), the genomic material of some viruses and a
replication intermediate in others, is recognized by multiple signaling receptors that initiate
the anti-viral response1. Viruses have developed mechanisms to circumvent the anti-viral
response by targeting components of the signaling pathway. An example of one such
pathway is the TLR3 signaling pathway, which contains a kinase complex that activates
interferon regulatory factor 3 (IRF3), leading to production of type I interferons. The
kinase complex consists of a scaffold protein, NAK-associated protein 1 (NAP1), and two
kinases, TANK-binding kinase 1 (TBK-1) and IκB kinase epsilon (IKKε). A fourty
residue sequence in NAP1 was discovered that mediated its interaction with TBK1 and
IKKε, termed the kinase binding domain (KBD)1. However, the function of NAP1 in
mediating kinase activation is unknown and understanding this is the long-term goal of this
x

xi
project. The goal of this thesis was to test the dependency of NAP1’s dimeric structure on
mediating interactions with the kinases. Biochemical characterization of recombinant
targets was completed using size-exclusion chromatography (SEC) and NAP1 KBD WT
eluted as a dimeric species. CFP/YFP/Alexa Fluor 546 fusion proteins of the NAP1 KBD
and scaffold binding motif (SBM) of the kinases, TBK-1 and IKKε, were generated to
assess interactions using fluorescence resonance energy transfer (FRET). NAP1 KBD
directly interacts with TBK1 and IKKε, with low micromolar affinity in vitro.
Mutagenesis was attempted to identify the residues necessary for NAP1 dimerization and
any effect dimerization may have on kinase recognition. This thesis shows data to support
that NAP1 KBD forms stable homo-oligomers and directly interacts with a small Cterminal portion of TBK1 and IKKε.

Chapter 1. Introduction
Protein-protein interactions are responsible for a great variety of cellular functions.
In the most basic sense, a protein-protein interaction occurs when two proteins come
together and form some type of interaction. Protein-protein interactions are a common
form of communication in signaling. For instance, when two proteins bind one another,
activation of a different protein, post-translational modification, or recruitment of other
proteins can occur. This recruitment process can be performed by a class of proteins
known as scaffold proteins, which act as docking stations for the formation of a protein
complex, which can lead to production of type I inteferons (IFNs), Nuclear Factor-KappaB
(NF-kB), as well as, downstream signaling to chemokines and cytokines, to destroy
invading pathogens.
Over the last several decades, pathogens have acquired the means to evade antiviral signaling2 or block receptor recognition3 as a means to promote pathogen survival and
replication. Viral proteins are known to interact with components of the anti-viral
signaling response and can disable the host from sequestering the pathogen’s genomic
material, as well as, inhibit phosphorylation-mediated signaling and block protein complex
formation. Therefore, structurally characterizing the domains involved in these interactions
and how they may form complexes with other proteins is vital to understanding how these
interactions mediate cellular processes and how to counter viral evasion.
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1.1 The Innate Immune System

The immune response is comprised of two parts: innate and adaptive immunity,
both are essential for a complete immune response. The innate immune response is the
first line of defense, against invading pathogens, with dendritic cells constantly sampling
cells, both self and non-self alike, to monitor the body for an infection. When an infected
cell is spotted this is where the macrophages come in to do their work. Macrophages are
known for engulfing foreign cells, via a process called phagocytosis, that are then digested
internally and cause the release of cytokines and chemokines to transmit a local
inflammatory response and prevent the spread of the invading pathogen to nearby cells4.
This is one of the two main functions of the innate immune response, with the other
function being the activation of the adaptive immune response.
For example, the presence of a viral pathogen often leads to the production of
interferon. Interferons are aptly named because of their ability to “interfere” with invading
pathogen’s replication process4. Type-I interferons’, such as IFN-α and IFN-β, role is to
mediate the activation of cytokines and chemokines to help prevent pathogen replication in
infected cells. Additionally, this activation can cause upregulation of major
histocompatibility complex (MHC) molecules on uninfected cells5. There are two classes
of MHC molecules: class I and class II molecules; where class I molecules present
peptides derived from cytosolic proteins. Class II molecules, which are only found on a
few specialized cell types, such as macrophages, dendritic cells and B cells, present
peptides derived from extracellular proteins. However, both types of molecules present
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peptides derived from infecting pathogens for recognition by T cells, to help clear the
infection, as part of the adaptive immune response.
Mainly antibodies and lymphocytes carry out the adaptive immune response, which
allows for a specific response to the invading pathogen. However, it is the connection
between the innate and adaptive response that is critical to fighting off the viral infection.
Nonetheless, the innate and adaptive immunity responses require different
recognition sources for activation. While the adaptive response relies on an antigenspecific response and the innate immune response is dependent on recognition of a set of
evolutionarily conserved pathogen elements, otherwise known as pathogen-associated
molecular patterns (PAMPs)5. These PAMPs form a direct interaction with a class of host
receptors known as pattern recognition receptors (PRRs) that mediate the innate immune
response5. The recognition of PAMPs instead of self is what differentiates between an
appropriate immune response and an over-active or autoimmune response, which can cause
a variety of illnesses.
For everything the immune response does well there are also a few drawbacks, the
innate immune system can also lose its ability to distinguish between self and non-self,
targeting endogenous cells as infectious agents leading to autoimmune diseases such as
autoimmune diabetics, liver disease and lupus nephritis, a kidney autoimmune disease6.
Furthermore, the innate immune response may also over-respond to non-infectious agents,
creating symptoms of what are commonly referred to as allergies. While seasonal allergies
are generally a nuisance, allergic reactions to things such as nuts or dairy can be fatal7.
Furthermore, over the last several decades pathogens have acquired the means to evade
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receptor recognition or block anti-viral signaling as a means to promote pathogen survival
and replication (2,3).

1.2 Pattern Recognition Receptors

The immune system response and more specifically the innate immune response
varies depending on the evolutionarily conserved pathogen element, or PAMP, that is
recognized. This allows the human body to ignore self-molecules while focusing solely on
finding, containing and destroying foreign molecules2. The wide range of PRRs allows the
human body to recognize an array of structural distinct bacterial and viral particles. There
are three localization types of PRRs: membrane-bound, cytoplasmic and secreted. The
membrane-bound PRRs are further classified into three subgroups: receptor kinases, which
originated in plants, and the toll-like receptors (TLRs) and the mannose receptor, which are
both found in humans4.
The mannose receptors, primarily present on the surface of innate immune cells,
recognize and bind to mannose repeats of infectious agents2. This activation triggers
endocytosis and phagocytosis of the invading pathogen. As previously described, the
engulfing of the invading particle and its subsequent digestion allows for peptide
presentation of the foreign molecule via MHC molecules, which lead to eventual targeting
and killing by the cytotoxic T cells.
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Recognition of both extracellular (TLR1,2,4,5,6,10) or endosomal (TLR3,7,8,9)
PAMPs, including bacterial lipoproteins (i.e LPS) and DNA-based ligands (i.e dsRNA), is
mediated by an array of transmembrane proteins known as TLRs. Toll-like receptors were
first discovered in Drosophila and are known to trigger a series of mechanisms leading to
the synthesis and secretion of cytokines and transcription factors that are crucial to the
development of innate and adaptative immune responses. In humans, there are currently
eleven such receptors (TLR1-11). Interaction of TLRs with their specific PAMP induces a
wide variety of signaling cascades consisting of NF-κB and type I interferon signaling,
MAP kinase pathways and apoptosis and autophagy. These pathways result in secretion of
pro-inflammatory cytokines and chemokines, as well as, transcription factors necessary to
activate the adaptive immune response and generate a complete immune response3.

1.3 Activation of type I Interferons and NF-κB signaling

One such PAMP, double stranded RNA (dsRNA), the genome of some viruses, can
be recognized by a variety of receptors. TLR3, retinoic acid inducible gene-1 (RIG-I),
melanoma differentiation associated gene 5 (MDA5) and dsRNA-dependent protein kinase
receptor (PKR) all bind dsRNA. However, these receptor have different cellular
localization, which leads to different downstream signaling. TLR-3 is located in the
endosome, whereas RIG-I, MDA-5 and PKR are located in the cytoplasm6. For example,
when TLR3 binds dsRNA, activation can lead to three distinct signaling pathways,
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resulting in production of type I Interferons or NF-kB and a third involving the cleavage of
caspase 8, which leads to apoptosis (Figure 1).
In the pathway leading to production of type I Interferons, the signaling cascade is
initiated when Toll/Interleukin 1 receptor (TIR)-domain-containing adapter inducinginterferon-β (TRIF) is recruited to TLR3’s interior-signaling domain. TRIF via tumor
necrosis factor receptor-associated factor 3 (TRAF3) interacts with a scaffold protein to
mediate downstream signaling. Currently, two scaffold proteins; Nak-associated protein 1
(NAP1) and Similar to NAP1 TBK1 adaptor (SINTBAD) have been identified. The
scaffold protein(s) act as a docking site for two kinases, TRAF family member-associated
NFKB activator (TANK)-binding kinase-1 (TBK1) and IκB kinase epsilon (IKKε).
Together, the scaffold protein(s) and kinase(s) form a kinase complex. The exact make-up
of the kinase complex is not fully understood. The activated kinases can phosphorylate
interferon-regulatory factor 3/7 (IRF3/7) allowing these transcription factors to dimerize
and traffic to the nucleus to initiate transcription of the interferon-β gene (IFN-β). Upon
transcription and release of IFN-β, it can bind to the downstream interferon alpha-receptor
1/2 (IFNAR1/2), which triggers the JAK/STAT pathways and leads to activation of a host
of interferon-stimulated genes. This is the end result of the interferon response that allows
for halting the viral replication of the invading pathogen and hopefully apoptosis of the
viral-infected cells.
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In addition to the IRF3/7 pathway, TRIF can also initiate the nuclear factor- kappa
B (NF-κB) essential modulator (NEMO/IKKγ) pathway, which leads to the formation of a
kinase complex, as well. Despite the formation of a kinase complex, like the IRF3/7
pathway, these pathways have some distinct differences. NEMO causes recruitment of
two different kinases, Iκ-B kinase beta (IKKβ) and Iκ-B kinase alpha (IKKα), to form a
kinase complex (Figure 2A). A partial crystal structure of the kinase complex8 has been
solved; involving the minimal kinase-binding domain (KBD) of NEMO, NEMO44-111,
which structurally is a dimer, binding two identical copies of a peptide that was generated
from a conserved NEMO-binding domain sequence found in the two kinases, IKKα and
IKKβ, sequence (Figure 2B). This particular conserved region is not present in the
TBK1/IKKε kinase complex. However, a unique conserved site, at the C-terminus, has
been discovered in our lab via sequence alignments.

9
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1.4 NAP1-TBK1 mediated type I Interferon Signaling

Both the NAP1 and SINTBAD scaffold proteins, also have a conserved site, that have
been shown to recognize the kinases, TBK1 and IKKε (Figure 3). NAP1 has also been
1

shown to bind SINTBAD; questioning whether it functions independently with the kinases
or with the aid of another scaffold protein(s)1. These protein-interaction domains are used
to form large molecular weight protein interaction networks (PINs). In fact, both NAP1
and TBK1 were components of high molecular weight complexes in TLR3 unstimulated
HeLa cells9. In addition, both of these scaffold proteins have multiple predicted coiled-coil
domains, which are rod-like alpha helices that are known to mediate protein-protein
interactions.

11
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The hypothesis is that NAP1’s protein domains have interaction specificity that has a
direct impact on its signaling (Figure 4). This hypothesis suggests that the CC domain
region of NAP1, residues 1-200, which highly alpha helical in structure, mediate its ability
to homo-dimerize. This homo-dimerization brings the kinase-binding domains in close
proximity that they have also been shown to homo-dimerize, but more importantly is the
hetero-interactions they form with the kinases’ scaffold-bindind motif1. NAP1’s ability to
behave as a dimer, may be necessary for NAP1’s kinase-binding domain’s heterointeractions with the kinase, which is necessary for downstream signaling and production
of type I IFNs. The end result being to better understand the TLR3-dependent PIN and
how it may be manipulated to control disease states.
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Chapter 2. Materials and Methods
2.1 Bacterial Production of Recombinant Protein domains

All bacterial constructs discussed below were DNA sequence confirmed and then
transformed into BL21 Codon Plus per manufacturer’s protocol (Stratagene). For protein
expression, 50ml cultures were grown at 37 degrees Celsius and 200rpm in Lennox Broth
(LB) media and ampicillin overnight and used to inoculate media for large-scale protein
expression per manufacturer’s protocol. Cells continued to grow at 37 degrees Celsius for
four to six hours (2.1.2) or at 20 degrees Celsius overnight (2.1.1 and 2.1.3), before
harvesting. Cells were harvested by centrifugation, 8000 rpm for 20 minutes, and cell
pellets were stored at -80°C.

2.1.1 CFP/YFP Tagged Protein Purification

All constructs used for FRET assays were made prior to starting on this project (CFP
NAP1 KBD, CFP, YFP, YFP TBK1 SBM, GST TBK1 SBM and GST IKKε SBM).
However, all CFP and YFP fluorescent-tagged constructs were found to be dimeric.
Quikchange mutagenesis kits (Stratagene) that employed standard molecular biology and
polymerase chain reaction (PCR) techniques were used to generate monomeric fluorescenttagged (A206K) constructs as per manufacturer’s protocol. An additional mutation was
performed to change YFP constructs to Citrine variants (Q69M). Constructs made include:
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mCFP NAP1 KBD, mCFP, mCitrine TBK1 SBM, mCitrine. All CFP/YFP constructs are
in pET15b, a bacterial expression vector that includes an N-terminal 6xHistidine tag for
immobilized metal affinity chromatography purification following expression. Additional
mutants were made to the mCFP NAP1 KBD to test their effects on dimer stability.
For purification, cell pellets were resuspended in Binding Buffer (20mM PO4 (pH 8),
500mM NaCl, 2mM MgCl2 and 1mM beta-mercaptoethanol (βME) including 1 protease
inhibitor tablet) and purified per manufacturer’s protocol (Qiagen). Cell lysis was
performed, on ice, using a Avestin C3 emulsifier instrument. Passage was performed 3-4
times at 15K-20K psi. Run program “1ml Histrap cfp proteins RJC” while collecting 1ml
fractions using the AKTA system at 4 degrees Celsius. This program washes the column
with 20 CV of 100% Binding Buffer, 10 CV gradient from 0 to 10% Elution Buffer,
washes with 5 CV of 10% Elution Buffer, 25 CV gradient from 10 to 100% Elution Buffer
and washes with 10 CV of 100% Elution Buffer. Peak fractions are analyzed by SDSPAGE gel analysis for target protein and visualized with coomassie blue stain. Histrap
column is regenerated per manufacturer’s instructions (Qiagen).

2.1.2 Purification and Refolding of Recombinant Protein

NAP1CC, the first 200 amino acids, was expressed as insoluble material. To purify
the insoluble NAP1CC, the insoluble protein was extracted from the bacterial pellet using
6M GuHCl. Purification by nickel-nitrilotriacetic acid (Ni-NTA) resin was completed
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following the manufacturer’s instructions for batch purification under denaturing
conditions (Qiagen).

2.1.3 Glutathione-S-Transferase fusion tagged construct purification

The GST fusion proteins are in the pGEX-4T1 vector, a bacterial expression vector
that includes a Glutathione-S-transferase tag for affinity chromatography purification
following expression, per manufacturer’s protocol (GE Healthcare). Quikchange
mutagenesis kits (Stratagene) that employed standard molecular biology and polymerase
chain reaction (PCR) techniques were used to mutate a valine to a cystine residue at the Nterminus of the TBK1 SBM peptide to allow for linkage with the Alexa-Fluor 546
molecule.

2.2 Baculovirus Production of Recombinant kinases
2.2.1 pFastbac Construct Preparation

Dr. Katherine Fitzgerald (UMass-Amherst) kindly provided a pFASTBAC vector
containing an N-terminal FLAG-affinity tag followed by the TBK1 gene. The IKKε gene
was later cloned into the same expression vector using primers that contained unique
restriction sites (5’ BamHI and 3’ SpeI) for the pFASTBac vector multiple cloning site.
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2.2.2 Bacmid Generation

Sequence confirmed IKKε pFASTBac and TBK-1 pFASTBac DNA was
transformed into DH10Bac competent cells per manufacturer’s protocol (Invitrogen).

2.2.3 Bacmid DNA Purification

Overnight cultures of pFASTBac transfected DH10Bac cells were pelleted at
14.000 x g for 10 minutes at room temperature. DNA was extracted via Qiagen mini-prep
kit, but modified to the Bac-to-Baculovirus Invitrogen protocol.

2.2.4 Insect Cell Virus Propagation

All insect cell work was carried out using sterile technique in a laminar flow hood,
biosafety cabinet IIA. Sf-9 cells were cultured in Hyclone SF-X Media (Thermo
Scientific). For bacmid transfection, again Bac-to-baculovirus protocol was followed
(Invitrogen).

2.2.5 Determining Viral Titer

Viral titer plaquing assays to determine viral titer were completed as per Bac-to-Bac
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instruction manual (Invitrogen). Sf-9 cells were plated at a density of 1.0 x 106 cells/well in
two 6-well culture plates. Cells were allowed to adhere at room temperature for 1 hour.
Meanwhile, serial dilutions of P2 viral stock were made from 10-1 to 10-8 fold dilutions in
SF-X media. Cell adherence is confirmed before removal of media. Media is then removed
from wells and replaced with 1 ml of diluted virus (from 10-3 to 10-8 ). Each dilution of
virus was done in duplicate, along with a control (no viral addition). Wells were allowed to
incubate with virus for 1 hour at room temperature on an orbital shaker, slow speed. Low
melting temperature agarose (4 %, 10 ml) and 30 ml of SF-X media were warmed to 37°C,
and then combined to make plaquing media. After incubation, plates were returned to
hood, and plaquing media was allowed to cool but not thicken to prevent cell death. Viral
dilution media was removed from cells, and 2ml of plaquing media (cooled slightly) was
added to wells, slow addition along the wall of the well. Plaquing media was allowed to set
for 10-20 minutes with the lid slightly cracked to avoid condensation. Plates were placed in
a virus-specific incubator at 27°C for 4 days. After four days, 1 ml neutral red staining
solution, consisting of 1% agarose, 62.5 µg/ml neutral red stain in SFX media, was added to
each well to stain the plaques. Agarose was allowed to harden and plates were returned to
humidified incubator for 2-3 days. Plaques (cleared areas) were counted for each well, and
averaged for each dilution. Titer was calculated by:

Titer (pfu/ml) = (# of plaques) x (dilution factor) x (1ml of inoculum/well)
Viral stocks were replenished using the protocol described for P2 viral stock and titred as
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described above.

2.2.6 Baculovirus Expression and Protein Purification

Sf9 cells cultured in suspension were infected with FLAG-tagged TBK1 or IKKε
incorporated baculovirus as described in the literature10 to express the kinases. The cells
were infected at a cell density of 1.5 x 106 cells/ml with a multiplicity of infection (MOI)
of three. Cells were harvested fourty-eight hours post-infection and then lysed by
emulsification (Avestin Emulsiflex C3) at 20,000 psi. The kinases were purified from
clarified cell lysates by anit-FLAG M2-agarose affinity column chromatography as per
manufacturer’s protocol (Sigma) and eluted using 0.34mg/ml of FLAG peptide. SEC was
performed to remove the FLAG peptide from the kinase solution. Fractions containing
kinase were concentrated, where the concentration was determined by Biorad assay with a
1000-fold dilution of protein to Biorad reagent. Kinase was stored at -80 degrees Celsius
in kinase storage buffer: 20mM Tris-HCl (pH 7.6), 150mM NaCl, 0.1% Nonidet P-40,
10% glycerol, 20mM NaF, 20mM β-glycerophosphate, 1mM EDTA, 5mM DTT, 1 EDTAfree protease inhibitor tablet, 0.1%BSA as detailed10.

2.3 mCFP NAP1 KBD Protein Interactions
2.3.1 Molecular Modeling
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The Protein Databank (PDB) was used to find a related structure of a coiled-coil
domain protein. The crystal structure of the C-terminal region of striated muscle alphatropomyosin (1KQL) was used as a template and all the residues were mutated to match
the target sequence (NAP1 216-255) using Pymol. Once mutated the structure was energy
minimized using a program called PHIEX. Following minimization, two copies of the
structure were sent for analysis for docking interactions, using a program called ZDOCK,
which holds one structure fixed and rotates the other structure to it and outputs possible
interactions arrangements for the pair. Possible complexes are scored and ranked based on
shape complementarity, desolvation, electrostatics and free energy change.
2.3.2 Size Exclusion Chromatography

Elutions from Ni-NTA purification and FLAG purification were separated on a
Superdex™ 200 16/60 prep grade column (GE Healthcare) pre-equilibrated in 20 mM
HEPES, pH 7.5, 150 mM NaCl and 1 mM βME (Ni-NTA purifications) and 20 mM
HEPES, pH 7.5, 500 mM NaCl, 5% glycerol and 1 mM DTT (FLAG purifications),
respectively. Elution volumes at peak maximums were converted to Kav and compared to a
standard curve (Kav versus log molecular weight) based upon globular standards of known
molecular weights (previously derived) using this equation:
Kav =

elution volume – void volume
total volume – void volume

Peak fractions for all runs were analyzed by 10% SDS-PAGE and visualized with
coomassie blue stain.
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2.3.3 Fluorescence Resonance Energy Transfer
The kinase-binding domain (KBD) of NAP1 was linked to cyan fluorescent protein
(CFP) and the kinase’s interaction motif was fused to citrine fluorescent protein (CitFP).
Fluorescence resonance energy transfer (FRET) between CFP and CitFP was measured to
assess interactions, by exciting at 430nm and following emission at 530nm. Alternatively,
the kinase’s interaction motif was conjugated to the fluorophore Alexa Fluor 546 (AF546).
Again, examining the interactions, by exciting at 430nm and following emission at 570nm.
Fluorescence measurements were performed using a Fluorescence Spectrophotometer
(instrument name). The excitation and emission bandpass were both set at a value of 2nm.
Emission spectra were collected from a range of 450nm to 600nm with data points being
collected every nm and each spectrum was collected three times and averaged.

2.4 Purification and Isolation of IKKε SBM-546 labeling

Upon successful purification of the GST IKKε SBM protein it was coupled with
mCFP NAP1 KBD were examined for hetero-interactions via fluorescent resonance energy
transfer (FRET). Prior to completing the FRET experiments, IKKε SBM was cleaved,
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using 10U thrombin/mg target protein, to separate the peptide from the GST-tag. Upon
successful cleavage of the fusion protein, free GST-tag is allowed to bind to GlutathoineS-transferase 4B resin and thrombin is allowed to bind benzamidine resin, thus, leaving
only the IKKε peptide in the supernatant. Upon isolation of the IKKε peptide, verification
analysis using mass spectrometry (MS) was performed by Jimmy Marion (of the Bell lab).
After confirmation of successful peptide isolation the peptide is labeled using a small
molecule fluorophore, Alexa-Fluor 546, per manufacturer’s protocol (Invitrogen). This
process is verified using MS that was performed by Jimmy Marion (of the Bell lab).

2.5 Protein Concentration

Protein concentrations were determined by BioRad protein assay (BioRad) as per
manufacturer’s protocol. As needed, protein samples were concentrated by ultrafiltration
(Amicon Ultrafiltration Units).

2.6 Circular Dichroism and Thermal Melt

NAP1CC sample were dialyzed into 100 mM sodium phosphate, pH 7, 150mM
NaCl, 5% glycerol overnight at 4°C. Dialysis buffer was retained as a buffer blank. CD
spectra (190-300nm) were collected on a Jasco 720 Circular Dichroism Spectrometer via
collaboration with Dr. Ellis Bell at the University of Richmond. Five individual spectra
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collecting data points every 0.1nm were collected averaged and Savitz-Golay smoothed
using the Jasco Spectra Manager software.
Thermal melt data were collected from 4°C-90°C at A222nm. Data was collected at 1
degree Celsius intervals. Data were Savitz-Golay smoothed using the Jasco Spectra
Manager software.
2.7 Analytical Ultracentrifugation (work done by R. Ghirlando)

Sedimentation velocity experiments were completed by R. Ghirlando (NIH). Data
was collected at 4 degrees Celsius, 55K rpm and various protein concentrations (33134µM) 0.435 to 3.49mg/ml in 20mM HEPES (pH 7.5), 150mM NaCl and 1mM βME.
Dialysis buffer was retained as a buffer blank. Protein concentrations were determined by
Biorad assay (2.4). Data was analyzed in terms of a continuous c(s) sedimenting species,
which provides a concentration profile (c) for each sedimenting species with a
sedimentation coefficient s. Data was fitted using SEDFIT program. Plots were completed
showing the concentration (in terms of A280) as a function of best fit (s20w).

Chapter 3. Results
Toll-like receptor 3 (TLR3) is stimulated by dsRNA, the viral genomic material in
some viruses or a viral replication intermediate in others. This stimulation initiates
signaling cascades that lead to the activation of nuclear factor kappa B (NF-κB) and
IRF3/7. Within the TLR3 signaling cascade that activates interferon regulatory factor 3/7
(IRF3/7), two scaffold proteins, Nak-associated protein 1 (NAP1) and Similar to NAP1TBK1 adaptor (SINTBAD), can recruit and bind two kinases, TRAF family memberassociated NFKB activator (TANK)-binding kinase 1 (TBK1) and IkB kinase epsilon
(IKKε), which phosphorylate IRF3/7 and promote production of type I interferons (IFNs),
NF-kB, as well as, downstream signaling to chemokines and cytokines, to destroy invading
pathogens.

3.1 Nak-associated protein 1 (NAP1) interactions via coiled-coil (CC) domain
3.1.1 Expression and Purification

Full-length NAP1 was expressed as insoluble material via bacterial expression. So,
quikchange mutagenesis was performed to truncate the NAP1 full-length protein to contain
only its first 200 amino acids, NAP1CC (residues 1-200) (Figure 5). This construct was
generated in pET15b, a bacterial expression vector that includes an N-terminal 6xHistidine
tag for immobilized metal affinity chromatography purification following expression.
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However, NAP1CC was also expressed as insoluble material. To purify the insoluble
NAP1CC, the bacterial pellet was resuspended and the protein unfolded using 6Mguanidine hydrochloride (GuHCl). Purification by nickel-nitrilotriacetic acid (Ni-NTA)
resin was completed following the manufacturer’s instructions for batch purification under
denaturing conditions (Qiagen). NAP1CC was eluted in 5ml aliquots with 0.5M imidazole
in binding buffer. Purity was assessed by separation by SDS-PAGE and coomassie stain
(Figure NAP1CC purification)
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3.1.2 Circular Dichroism and Thermal Melt

Successful refolding was assessed by examining secondary structure content using
circular dichroism (CD). A UV-Vis scan was collected, via CD, and can detect secondary
structures motifs, such as alpha helices and beta sheets. NAP1CC, which encompasses
only the CC region, should contain almost exclusively alpha helical secondary structure.
The CD spectrum of NAP1CC shows two negative ellipticity peaks at 222 and 208nm
(Figure 6A), which is indicative of alpha helical secondary structure. Furthermore, the
thermal melt data (Figure 6B) indicates a stepwise loss of helical content as the
temperature is increased. This suggests that NAP1CC forms higher order oligomers and
that as the temperature is increased the monomers dissociate and eventually the individual
alpha helices are separated, as well.
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3.1.3 Size-exclusion chromatography (SEC)

To access the oligomeric state of the NAP1CC protein (Figure 7A), SEC experiments
were completed. SEC separates proteins in the liquid phase as a function of their ability to
interact with a column matrix. Larger proteins elute first because of their inability to
interact with the matrix while smaller proteins elute later. An approximate molecular
weight of an eluted species can be determined based upon the elution pattern of globular
protein with well-characterized molecular weights. NAP1CC was tested at three different
concentrations: 0.1mg/ml, 1.2mg/ml and 20mg/ml (Figure 7B). All of the experiments
were completed on a Superdex 200 column (GE) in the following buffer: 20 mM HEPES
(pH 7.5), 150mM NaCl, 5% glycerol and 1mM DTT.
The elution profile of NAP1CC indicated the major species eluted as a hexamer (Figure
?) with a minor peak eluting as a 12-mer. CC domains are rod-like structures, which
tumble in solution with a larger radius than a globular protein with similar molecular
weight. Therefore, while SEC is useful in determining purity of these types of protein
samples, it may only approximate the molecular weight.

30

31
3.1.4 Analytical Ultracentrifugation (AUC) (completed by Dr. R. Ghirlando)

As a complementary technique AUC was utilized to obtain a more accurate molecular
weight. The data collected via AUC includes sedimentation and diffusion coefficients that
contain information concerning the size and shape of a protein. A buoyancy term is also
derived, which can account for the tumbling limitations of SEC. Using all these pieces of
data, a more accurate molecular weight can be calculated. In collaboration with Dr.
Rodolfo Ghirlando (NIDDK, NIH), AUC sedimentation velocity studies were performed
on the “hexamer” species to confirm the data collected by SEC (Figure 7). Concentrations
ranging from 17 to 137mM (0.435 to 3.49mg/ml) were tested to determine oligomeric state
and examine concentration dependence of association (Figure 8). AUC analysis of this
protein indicates that NAP1CC actually behaves as a dimer in vitro. This validated the
need to include both SEC and AUC to determine accurate homointeractions of these
coiled-coil domain proteins.
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NAP1 (1-200)

Sedimentation Coeff. (S)
Figure 8. NAP1CC is a dimeric species by AUC. Analytical ultracentrifugation data, sedimentation coefficient (S) profiles, of
NAP1CC were collected for samples from a concentration range of 17.2 to 137 µM in 0.02 M HEPES, pH 7.5, 0.5 M NaCl, 5%
glycerol, 1 mM βME. Samples were run at 55 K rpm and 20°C. The major peak having an S value of 2.67 corresponds to a
molecular weight of ~44 kDa just slightly less than a NAP1CC dimer (~51 kDa).

AUC data were collected by Dr. R. Ghirlando at NIDDK, NIH, Bethesda, MD.
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3.2 Attempts to obtain full-length TBK1 and IKKε via Baculovirus system
3.2.1 Generation of TBK1/IKKε full-length Baculovirus

Dr. Katherine Fitzgerald kindly provided the pFASTBAC vector containing an Nterminal FLAG-tagged TBK1 gene (Figure 9A). This vector backbone was used to
construct an equivalent expression vector with the IKKε gene using standard molecular
biology techniques (Stratagene). Both TBK1 and IKKε pFASTBAC constructs were then
DNA sequence confirmed. Bacmid DNA was generated using Invitrogen’s Bac-to-Bac®
Baculovirus protocol (Figure 9B-C). Virus was amplified in additional cultures to yield
500ml of viable virus per construct at a titer between 1x108 plaque forming units/milliliter
(pfU/ml) and 1x109 pfU/ml.
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3.2.2 Expresssion and Purification of TBK1/IKKε FLAG-tagged proteins

Sf9 cells cultured in suspension were infected with TBK1 or IKKε incorporated
baculovirus as described in the literature (14) to express the kinases. The cells were
infected at a cell density of 1.5-2 x 106 cells/ml with a multiplicity of infection (MOI) of
three. Cells were harvested fourty-eight hours post-infection and then lysed by
emulsification (Avestin Emulsiflex C3) at 20,000 psi. The kinases were purified from
clarified cell lysates using anit-FLAG M2-agarose affinity column chromatography as per
manufacturer’s protocol (Sigma) and eluted using 0.34mg/ml FLAG peptide in two
twenty-five milliliter fractions and concentrated by ultra-filtration (Amicon Ultra- 3000
molecular-weight cut-off (MWCO). To remove FLAG peptide from elution fractions it
was purified by separation on a Superdex 200 column (Figure 10) and checked for purity
by separation by SDS-PAGE, coomassie stain (Figure 11A). Fractions containing kinase
were concentrated and protein concentration was determined by Biorad assay. Kinases
were stored at -80 degrees Celsius in kinase storage buffer: 20mM Tris-HCl (pH 7.6),
150mM NaCl, 0.1% Nonidet P-40, 10% glycerol, 20mM NaF, 20mM β-glycerophosphate,
1mM EDTA, 5mM DTT, 1 EDTA-free protease inhibitor tablet, 0.1%BSA as detailed
(14). Low protein yields, limited the use of recombinant kinase proteins in future assays.
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3.3 Nak-associated protein 1 (NAP1) interactions via kinase-binding domain (KBD)
interactions
3.3.1 Generation of CFP/YFP-tagged constructs

Thus, in order to examine the potential interactions between TBK1/IKKε and the
scaffold protein, NAP1, a smaller domain of the kinases, as well as, for the scaffold
protein, were generated. Previous work completed in the lab lead to generation of cyan
fluorescent protein (CFP) and yellow fluorescent protein (YFP) fusion proteins containing
NAP1 kinase-binding domain (KBD) and TBK1 scaffold-binding motif (SBM) peptides.
For example, NAP1 KBD (residues 216-255), the target gene, was inserted into the
pET15b vector that included a N-terminal 6X His-tag followed downstream by a CFP
molecule and then the target gene (Figure 12A), in this case NAP1 KBD (residues 216255). A similar construct was generated using YFP that was fused with the SBM of TBK1
(residues 700-722), for Fluorescence-resonance energy transfer (FRET) pairing
experiments with NAP1 KBD. CFP and Citrine proteins, containing no peptides, were also
generated to serve as controls for the FRET experiments.
However, purification of these constructs showed that they all expressed as dimeric
species. It was determined that a key mutation needed to be made to force the
fluorophores to behave monomeric. Quikchange mutagenesis kits (Stratagene) that
employed standard molecular biology and polymerase chain reaction (PCR) techniques
were used, as per manufacturer’s protocol, to mutate residues to make the fluorescent
proteins monomeric (A206K). Furthermore, a mutation was introduced to change YFP to
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Citrine (Q69M), an YFP variant, because of its emission range overlap with CFP excitation
range, which is a requirement for good FRET pairing.
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A

ATG-6XHis-NdeI-FP-XhoI-insert-TAA-BamHI

pET15b

B

ATG-GSTtag-BamHI-insert-TAA-XhoI

pGEX-4T™1
Figure 12. NAP1 KBD is a dimeric species by SEC. A) Cartoon diagram of monomeric cyan fluorescent protein (mCFP) NAP1
KBD plasmid. B) Cartoon diagram of glutathione-S-transferase (GST) tagged kinase SBM plasmid. All constructs were generated
for use in fluorescence resonance energy transfer studies.

41

3.3.2 Generation of GST-TBK1/IKKε SBM for labeling with Alexa-Fluor 546

Both TBK1 and IKKε (687-709) SBMs were inserted into the pGEX-4T1 vector
(Figure 12B), a bacterial expression vector that includes an N-terminal Glutathione-Stransferase tag for affinity chromatography purification following expression. Quikchange
mutagenesis kits (Stratagene) that employed standard molecular biology and polymerase
chain reaction (PCR) techniques were used, as per manufacturer’s protocol, to insert a
cysteine residue at the N-terminal of the TBK1 SBM peptide that allows for linkage with
an Alexa-Fluor 546 molecule and use in small-molecule FRET experiments.
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3.3.3 Expression and Purification

The pET15b constructs are purified from cell lysates by binding to a Ni2+ charge
immobilized metal affinity chromatography (IMAC) resin, HISTRAP, washed with
binding buffer (20 mM NaPO4 (pH 8), 0.5M NaCl, 1mM βME) and eluted using a gradient
of imidizaole (0 – 0.5M) in binding buffer as modified per manufacturer’s instructions (GE
Healthcare). Fractions containing target protein, as assessed by separation on SDS-PAGE
and coomassie staining, were pooled, concentrated and further purified by separation on a
Superdex 200 column (Figure 13-14) and checked for purity by separation by SDS-PAGE,
coomassie staining (Figure 15A-B, 16A-B).
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The GST fusion proteins, using the pGEX-4T1 vector, were expressed in bacteria as a
soluble protein and purified from clarified cell lysates using standard protocol provided by
the manufacturer (GE Healthcare) for Glutathione Sepharose 4B resin and assessed for
purity by separation by SDS-PAGE and coomassie stain (Figure 11B). Following
successful purification of the GST IKKε SBM protein, the GST-tag was cleaved with
thrombin (10units/mg of target protein) per manufacturer’s protocol (GE Healthcare) and
confirmed via mass spectrometry (Figure 17A). Pure peptide was assessed for secondary
structure formation via CD spectrum (Figure 17B) and appears to have mainly alpha
helical content.

3.3.4 NAP1 KBD homo-interactions analyzed via SEC

The kinase binding domain (KBD) of NAP1 was also examined for homointeractions using SEC. During initial purification experiments it eluted as a dimer, while
the other CFP/Citrine-tagged proteins eluted as a monomer (Figure 13-14). To determine
if the dimer is concentration dependent, mCFP NAP1 KBD was run over a S200 tricorn
column (GE) in the following buffer: 20 mM HEPES (pH 7.5), 150mM NaCl, and 1mM
βME. mCFP NAP1 KBD was analyzed over the concentration range 1 to 6mg/ml (Figure
18). The results showed that, at concentrations below 2mg/ml, mCFP NAP1 KBD eluted
as a monomer, while at concentrations above this threshold it eluted as a dimeric species.
Furthermore, when mCFP, with no peptide fused, was analyzed at the 6mg/ml
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concentration it eluted as a monomeric species. Thus, the NAP1 KBD is mediating the
dimer formation and not the CFP molecule.
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3.3.5 NAP1 KBD homo-interactions assessed via a molecular model

It has been shown that the first 200 residues of the NAP1 protein (Figure 8) and the
NAP1 KBD (Figure 18) are dimeric in structure. Other data collected in the lab (data not
shown) has successfully expressed and purified GST-tagged NAP1 KBD (performed by
James Marion). CD was completed to assess the secondary structure of this region of
NAP1, which was determined to be almost exclusively alpha helical (data not shown).
Therefore, when the two adjacent domains were combined in either the head-to-head or
head-to-tail orientation, it becomes clear that, in order for both domains to have homointeractions, the NAP1 protein must be in a head-to-head confirmation (Figure 19).
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To identify the essential residues for maintaining the homo-dimer of NAP1 KBD a
molecular model was built; following the diagram in Figure 20. A single chain from the
striated muscle alpha-tropomyosin (1KQL) was used as template; its amino acids were
mutated to the NAP1 KBD (216-255) sequence using Pymol and energy minimized via
Phenix (Figure 21A). Identical copies of the NAP1 KBD sequence were input into
ZDOCK. Keeping one molecule stationary, the other was computationally docked to the
stationary molecule.
The program scored complexes based upon shape complementarity, desolvation,
electrostatics and free energy change. Additionally, based on analysis of previously
collected data, (Figure 19) head-to-head complexes in the top ten scored were examined.
Of the ten highest scores, only two were in the head-to-head confirmation. The two
highest scoring models that met this criteria are shown in, Figure 21B-C. Both were
analyzed, using Pymol, for residues that would form strong interactions at the interface of
the hydrophobic core, as well as, possible electrostatic interactions; hallmarks of coiledcoil domain structures, such as NAP1 KBD.
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A

NAP1 KBD
model

B

NAP1 KBD
Dimer model A

NAP1 KBD
Dimer model B

Figure 21. Molecular model of NAP1 KBD and dimer interface. A) NAP1 KBD model (residues 216-255) was built using
striated muscle alpha-tropomyosin and the GCN4 leucine zipper fusion structure (1KQL3) as template and then energy minimized
(Phenix4). B) Computational docking (ZDOCK5) was used to predict dimer interface of NAP1 KBD. From previous data, the
dimer must form a head-to-head interaction. The two highest scoring models that met this criteria are shown.
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3.4 Kinase-binding domain and Kinase Interactions
3.4.1 NAP1 KBD-TBK1 SBM Interactions

Successful purification of mCFP NAP1 KBD and mCitrine TBK1 SBM proteins
allowed for assessment of hetero-interactions, as well as, any kinase protein affinity to
NAP1, via FRET based assays.
Fluorescent properties of donor and acceptor
Fluorescence resonance energy transfer (FRET) is based on a couple properties. In
order to achieve FRET a couple properties must be met. First, the FRET pair, donor and
acceptor, must be in close contact, approximately 10-100 Angstroms. The FRET pair must
be in close contact to allow for energy transfer from the donor to the acceptor. In order to
achieve such a phenomenon, known as the spectral overlap, the emission spectrum of the
donor must overlap with the excitation spectrum of the acceptor. To determine where this
occurs for this particular FRET pair, the donor, mCFP NAP1 KBD or mCFP, was emitted
at 475nm and an excitation scan (from 300-450nm) and an emission scan (from 450650nm), exciting at 430nm, were collected separately for both mCFP NAP1 KBD and
mCFP (Figure 22). The acceptor, mCitrine TBK1 SBM or mCitrine, was emitted @
530nm and an excitation scan (from 300-525nm), and an emission scan (525-650nm),
exciting at @475nm, were collected (Figure 23), as well.
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FRET experimental set-up
Based on these spectra, the donor, mCFP NAP1 KBD, was excited at 430nm and
emission spectra were collected (from 450nm to 600nm) to observe the interaction between
mCFP NAP1 KBD and mCitrine TBK1 SBM (Figure 24), to obtain optimal experimental
results. A total of four scans were completed every 1nm for each concentration of the
acceptor. The concentration of the donor, mCFP NAP1 KBD, was held constant at 0.5µM,
a concentration low enough not to force dimerization of the mCFP molecule, and aliquot
into a set of cuvettes. While the acceptor, mCitrine TBK1 SBM was added to these
cuvettes separately at concentrations ranging from 0-6 µM, large enough to observe FRET
pairing. FRET buffer (20mM HEPES pH 7.5, 150mM NaCl, 1mM βME) was added to
maintain constant volume in all cuvettes.
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While the majority of the energy transfer from donor to acceptor is from the two
peptides interacting, it is possible to get non-specific interactions between the two
fluorphores, mCFP and mCitrine. To correct for this, the interaction between mCFP NAP1
KBD and mCitrine (Figure 25) was observed by excitation of the donor, mCFP NAP1
KBD, at 430nm and emission spectra were colleted (from 450nm to 600nm) to measure the
non-specific interaction. The experimental set-up was the same as described above.
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Data Analysis
Upon completion of the spectra, a correction factor is calculated, to adjust for
difference in fluorescence intensity between the mCFP and mCitrine fluorphores. This
correction factor is the fluorescence intensity between mCitrine:mCitrine TBK1 SBM at
530nm, the excitation maximum for mCitrine:
Fluorescence Intensity @ 530nm of mCitFP
Fluorescence Intensity @ 530nm of mCitFP TBK1 SBM

With this correction factor, (value of 1.4) any difference in fluorescence intensity between
the mCFP and mCitrine fluorophores:

(experimental FI @530nm)- (( control FI @530nm)/1.4)

After this correction is applied the net fluorescence (Figure 26A) was fit to a binding curve
(FI @ 530 vs. log [mCitFP TBK1 SBM (nM)] where the KD is approximately 2µM (Figure
26B).
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3.4.2 NAP1 KBD-IKKε SBM Interactions

Alexa-Fluor 546-Labeling of IKKε SBM peptide
Successful purification of pure IKKε SBM was labeled with Alexa-Fluor 546 per
manufacturer’s protocol (Invitrogen) and following the diagram in Figure 27. No mutation
was made, because a cysteine residue was already present at the N-terminus. Labeling
occurs through disulfide-linkage between the thiol groups of the cysteine residue and the
C5-malamide of the Alexa-Fluor.
Alexa-Fluor 546 (AF546), 1mg, is dissolved in 333µl of FRET buffer, for a final
concentration of .33µM. AF546 is added at the 3X the concentration of the target peptide
to label. FRET buffer is added for necessary dilutions. The reaction is allowed to go for 2
weeks at 4° Celsius and excess label is remove via a desalting column, 3x 3’ spins
@1500rpm. Successful labeling of peptide was assessed again via mass spectrometry
(Figure 17C), for use in small-molecule FRET experiments.
Fluorescent properties of donor and acceptor
To determine where the spectral overlap occurs for this particular FRET pair, the
acceptor, AF546 IKKε-SBM, was emit at 570nm and an excitation scan (from 300-565nm)
and an emission scan (from 550-650nm), exciting at 520nm, were collected separately
(Figure 28). The donor, mCFP NAP1 KBD, has already been characterized (Figure 22).
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FRET experimental set-up (Ellis Bell)
Based on these spectra, the donor, mCFP NAP1 KBD, was excited at 430nm and
emission spectra were collected (from 450nm to 650nm) to observe the interaction between
mCFP NAP1 KBD and AF546 IKKε SBM (data not shown), to obtain optimal
experimental results. A total of four scans were completed every 1nm for each
concentration of the acceptor. A set amount of the acceptor, AF546 IKKε, at unknown
concentration, was added to a cuvette and the donor, mCFP NAP1 KBD, was held titrated
in, at concentrations ranging from 0-3 µM, large enough to observe FRET pairing. FRET
buffer (20mM HEPES pH 7.5, 150mM NaCl, 1mM βME) was added to maintain constant
volume in all cuvettes. Scans were performed after the addition of each aliquot of mCFP
NAP1 KBD.
Again, non-specific interactions between the two fluorphores, mCFP and AF546
were corrected for. For this set-up, the same experiment was performed as for the
experimental, however, no AF546 IKKε SBM was added and only buffer was in the
cuvette to start and again mCFP NAP1 KBD was titrated in.
Data Analysis
This data was corrected by subtraction of the integrated area of the resonance
energy transfer (RET) signal for the control spectra from the experimental spectra. The
raw data was fit to a binding curve (integrated area of the RET signal vs. mCFP NAP1
KBD (µM)) where the KD is approximately 1µM (Figure 29). This agrees with the NAP1
KBD-TBK1 SBM data, indicating that mCFP NAP1 KBD interacts with both the kinase’s
SBMs at low-micromolar affinity.
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Chapter 4. Discussion
The data shows that NAP1 protein domains form head-to-head dimers. Furthermore,
homo-dimerization of the NAP1CC region may mediate homo-dimer formation of the
NAP1 KBD, but more importantly is the hetero-interactions they form with the kinases’
SBM. The CC domain region, as well as, NAP1’s ability to behave as a dimer, may
mediate NAP1 KBD’s hetero-interactions with the kinase. This interaction has been
shown to be necessary for IRF3 phosphorylation leading to production of type I IFNs.
It has previously been reported that the type I IFN pathway has a second scaffold
protein, SINTBAD. Both the NAP1 and SINTBAD scaffold proteins, have a conserved
site, specific for kinase, TBK1 and IKKε , recognition. NAP1 has also been shown to bind
1

SINTBAD; questioning whether it functions independently with the kinases or with the aid
of another scaffold protein(s)1. These protein-interaction domains are used to form large
molecular weight protein interaction networks (PINs). In fact, both NAP1 and TBK1 were
shown to be associated with high molecular weight complexes in TLR3 unstimulated HeLa
cells9. In addition, both of these scaffold proteins have multiple predicted coiled-coil
domains, which are rod-like alpha helices that are known to mediate protein-protein
interactions. However, the mechanism behind the NAP1-TBK1 interaction, which is
required for IRF3 phosphorylation leading to production of type I IFNs, is unknown.
While all the FRET data was collected with mCFP NAP1 KBD in its monomeric state, it
has not been determined if mCFP NAP1 KBD at dimeric concentrations would tighten
hetero-interactions with the kinases. This work is currently ongoing.
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As previously mentioned, the Randow group has identified some key residues that
have diminished the scaffold-kinase binding, which are colored orange in the helical wheel
representation (Figure 30). These residues are found on the dimer interface and necessary
for stabilizing the hydrophobic core. Conversely, mutation sites that had no effect on
kinase binding, because they lie outside the dimer interface, are colored purple (Figure 30).
Therefore, it is possible that dimer formation may enhance and stabilize hetero-interactions
with the kinases. Furthermore, polar amino acids have been shown to contribute to
specificity of hetero-dimer formation by favoring associations with complementary polar
groups. For example, Tyr-223 of the NAP1 KBD when mutated to Ala shows complete
loss of NAP1-TBK1 interaction. No such residue was reported for IKKε.
Extensive studies of coiled-coil domains have shown that in the formation of a
coiled-coil dimer that hydrophobic residues, particularily leucine residues, are found on
one face of the dimer and buried in the interior, which forms a hydrophobic core
stabilizing the dimer interaction. In fact, disruption of these leucine pairs even with other
hydrophobic residues has lead to destabilization of the dimer. This agrees with the
predicted residues we found from the NAP1 KBD model we built that may stabilize dimer
formation.
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Quikchange mutagenesis kits (Stratagene) that employ standard molecular biology
and polymerase chain reaction (PCR) techniques was performed, as per manufacturer’s
protocol, to mutate a few of these residues: Y223A, Q240A, L244S (and L226/233/247S),
E225A and E229A. Mutagenesis has been completed for the following residues: Y223A,
Q240A, L244S and E225A, highlighted in Figure 31A. The remaining mutations are
ongoing.
Initial purification of the completed mutations has yielded poor results of pure and
stable protein to use for future experiments (Figure 31B-C). However, purification of the
L244S mutant yielded enough sample (~3mg/ml) to analyze the oligomeric state (Figure
32) by analysis over the S200 Tricorn column (in 20mM HEPES pH 7.5, 150mM NaCl,
1mM βME). The elution pattern indicates that it is eluting as mainly a monomeric species.
However, this run would need to be repeated and additional concentrations tested to
confirm. This data suggests that the leucine residues are indeed required for dimer
stabilization. The rest of the leucines and other residues are currently being tested.
The previously described mutants will be assessed for dimeric structure using SEC
and NAP1-Kinase interactions via FRET to further elucidate the NAP1-TBK1/IKKε
trimeric complex formation in this protein-interaction network and more importantly its
specificity in downstream signaling.
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Upon completion of mutagenesis, the mutated proteins will be assessed for dimeric
structure using SEC and NAP1-Kinase interactions via FRET to further elucidate the
NAP1-TBK1/IKKε role is this protein-interaction network and more importantly its role in
mediating downstream signaling.

77
Literature Cited
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

Ryzhakov, G. and F. Randow, SINTBAD, a novel component of innate antiviral
immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J, 2007.
26(13): p. 3180-90.
Jin, H., et al., The VP35 protein of Ebola virus impairs dendritic cell maturation
induced by virus and lipopolysaccharide. J Gen Virol. 91(Pt 2): p. 352-61.
Bowie, A.G. and L. Unterholzner, Viral evasion and subversion of patternrecognition receptor signalling. Nat Rev Immunol, 2008. 8(12): p. 911-22.
Janeway, C.A.T., P. Walport, M. Shlomchik, M.J., Immuno-Biology; the immune
system in health and disease. 6th ed. 2005, New York: Garland Science. 823.
Paul, W.E., Fundamental Immunology. 5th Edition ed. 2003, Philadelphia:
Lippincott, Williams & Wilkins. 1687.
Vercammen, E., J. Staal, and R. Beyaert, Sensing of viral infection and activation
of innate immunity by toll-like receptor 3. Clin Microbiol Rev, 2008. 21(1): p. 1325.
Kandyil, R.M. and C.M. Davis, Shellfish allergy in children. Pediatr Allergy
Immunol, 2009. 20(5): p. 408-14; quiz 414.
Rushe, M., et al., Structure of a NEMO/IKK-associating domain reveals
architecture of the interaction site. Structure, 2008. 16(5): p. 798-808.
Fujita, F., et al., Identification of NAP1, a regulatory subunit of IkappaB kinaserelated kinases that potentiates NF-kappaB signaling. Mol Cell Biol, 2003. 23(21):
p. 7780-93.
Huynh, Q.K., et al., Kinetic mechanisms of IkappaB-related kinases (IKK)
inducible IKK and TBK-1 differ from IKK-1/IKK-2 heterodimer. J Biol Chem,
2002. 277(15): p. 12550-8.

